• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Autophagy-mediated tau pathology formation and propagation

Research Project

Project/Area Number 16K19057
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Pathological medical chemistry
Research InstitutionOsaka City University

Principal Investigator

Umeda Tomohiro  大阪市立大学, 大学院医学研究科, 助教 (70549790)

Project Period (FY) 2016-04-01 – 2019-03-31
Project Status Completed (Fiscal Year 2018)
Budget Amount *help
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2018: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2017: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2016: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Keywordsドラッグリポジショニング / タウ / リファンピシン / オートファジー / tau / 伝播 / 神経変性疾患 / 認知症 / アルツハイマー病 / 老化
Outline of Final Research Achievements

In this study, we found that intracellular tau aggregation was associated by selective-autophagy chaperon p62. P62-mediated tau aggregates were secreted to extracellular space depend on autophagy activity. And we succeeded in the generation of tau pathology transmission model based on our WT htau-Tg mouse. Furthermore, we found that the well-known drug “rifampicin” works as the autophagy restoration agent and the intranasal administration of rifampicin shows highly protective effects on the phenotypes of Alzheimer’s disease model mouse.

Academic Significance and Societal Importance of the Research Achievements

本研究で見出されたオートファジーのタウ病理形成への影響と、これらを抑制可能なrifampicinの薬効の発見は、既存医薬品のdrug-repositioningの有用性を示すとともに、他因子疾患ともいえる認知症に対してrifampicinが単剤でカクテル療法同等の効果を発揮可能であることを示している。今後臨床試験を経て、適応の拡大による臨床現場での使用を実現したい。

Report

(4 results)
  • 2018 Annual Research Report   Final Research Report ( PDF )
  • 2017 Research-status Report
  • 2016 Research-status Report
  • Research Products

    (5 results)

All 2018 2017 2016

All Journal Article (3 results) (of which Int'l Joint Research: 1 results,  Peer Reviewed: 3 results,  Open Access: 3 results,  Acknowledgement Compliant: 1 results) Presentation (2 results)

  • [Journal Article] Intranasal rifampicin for Alzheimer's disease prevention2018

    • Author(s)
      Tomohiro Umeda, Akiko Tanaka, Ayumi Sakai, Akira Yamamoto, Toshiyasu Sakane, Takami Tomiyama
    • Journal Title

      Alzheimer's & Dementia: Translational Research & Clinical Interventions

      Volume: 4 Issue: 1 Pages: 304-313

    • DOI

      10.1016/j.trci.2018.06.012

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Mutation-induced loss of APP function causes GABAergic depletion in recessive familial Alzheimer's disease : analysis of Osaka mutation-knockin mice2017

    • Author(s)
      Umeda Tomohiro、Kimura Tetsuya、Yoshida Kayo、Takao Keizo、Fujita Yuki、Matsuyama Shogo、Sakai Ayumi、Yamashita Minato、Yamashita Yuki、Ohnishi Kiyouhisa、Suzuki Mamiko、Takuma Hiroshi、Miyakawa Tsuyoshi、Takashima Akihiko、Morita Takashi、Mori Hiroshi、Tomiyama Takami
    • Journal Title

      Acta Neuropathol Commun

      Volume: 5 Issue: 1 Pages: 59

    • DOI

      10.1186/s40478-017-0461-5

    • NAID

      120006371271

    • URL

      https://ocu-omu.repo.nii.ac.jp/records/2019593

    • Related Report
      2017 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers2016

    • Author(s)
      Umeda T., Ono K., Sakai A., Yamashita M., Mizuguchi M, Klein W.L., Yamada M., Mori H., Tomiyama T
    • Journal Title

      Brain

      Volume: 139 Issue: 5 Pages: 1568-1586

    • DOI

      10.1093/brain/aww042

    • NAID

      120006371274

    • URL

      https://ocu-omu.repo.nii.ac.jp/records/2019690

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
  • [Presentation] 経鼻リファンピシン-リファンピシンの新しい投与経路による認知症予防2018

    • Author(s)
      梅田知宙、田中晶子、酒井亜由美、山本昌、坂根稔康、富山貴美
    • Organizer
      第37回 日本認知症学会 学術集会
    • Related Report
      2018 Annual Research Report
  • [Presentation] 既存医薬品リファンピシンはオリゴマーを標的とする認知症予防薬の有望な候補である2016

    • Author(s)
      梅田知宙, 小野賢二郎, 酒井亜由美, 山下港, 水口峰之, 山田正仁, 森啓, 富山貴美
    • Organizer
      第35回 日本認知症学会 学術集会
    • Place of Presentation
      東京国際フォーラム(東京都千代田区)
    • Year and Date
      2016-12-01
    • Related Report
      2016 Research-status Report

URL: 

Published: 2016-04-21   Modified: 2020-03-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi